About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 368075, 8 pages
http://dx.doi.org/10.1155/2012/368075
Research Article

1 1 1 I n -Labeled Cystine-Knot Peptides Based on the Agouti-Related Protein for Targeting Tumor Angiogenesis

1Department of Nuclear Medicine, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
2Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford Cancer Institute, and Bio-X Program, Canary Center at Stanford for Cancer Early Detection, Stanford University, Stanford, CA 94305, USA
3Department of Bioengineering, Stanford Cancer Institute, and Bio-X Program, Stanford University, Stanford, CA 94305, USA

Received 14 December 2011; Revised 29 January 2012; Accepted 30 January 2012

Academic Editor: David J. Yang

Copyright © 2012 Lei Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Saga, M. Koizumi, T. Furukawa, K. Yoshikawa, and Y. Fujibayashi, “Molecular imaging of cancer—evaluating characters of individual cancer by PET/SPECT imaging,” Cancer Science, vol. 100, no. 3, pp. 375–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Weissleder and U. Mahmood, “Molecular imaging,” Radiology, vol. 219, no. 2, pp. 316–333, 2001. View at Scopus
  3. T. F. Massoud and S. S. Gambhir, “Molecular imaging in living subjects: seeing fundamental biological processes in a new light,” Genes and Development, vol. 17, no. 5, pp. 545–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Mather, “Molecular imaging with bioconjugates in mouse models of cancer,” Bioconjugate Chemistry, vol. 20, no. 4, pp. 631–643, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. W. A. Weber, “Positron emission tomography as an imaging biomarker,” Journal of Clinical Oncology, vol. 24, no. 20, pp. 3282–3292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Kolmar, “Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins,” Current Opinion in Pharmacology, vol. 9, no. 5, pp. 608–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kolmar, “Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins,” FEBS Journal, vol. 275, no. 11, pp. 2684–2690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Silverman, A. M. Levin, J. L. Lahti, and J. R. Cochran, “Engineered cystine-knot peptides that bind αvβ3 integrin with antibody-like affinities,” Journal of Molecular Biology, vol. 385, no. 4, pp. 1064–1075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. O. Hynes, “Integrins: versatility, modulation, and signaling in cell adhesion,” Cell, vol. 69, no. 1, pp. 11–25, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. R. E. B. Seftor, E. A. Seftor, K. R. Gehlsen et al., “Role of the αvβ3 integrin in human melanoma cell invasion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 5, pp. 1557–1561, 1992. View at Scopus
  11. P. C. Brooks, R. A. F. Clark, and D. A. Cheresh, “Requirement of vascular integrin αvβ3 for angiogenesis,” Science, vol. 264, no. 5158, pp. 569–571, 1994. View at Scopus
  12. E. Chang, S. Liu, G. Gowrishankar et al., “Reproducibility study of [18F]FPP(RGD)2 uptake in murine models of human tumor xenografts,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 4, pp. 722–730, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Jiang, R. H. Kimura, Z. Miao et al., “Evaluation of a 64Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing αvβ3 integrin,” Journal of Nuclear Medicine, vol. 51, no. 2, pp. 251–258, 2010. View at Publisher · View at Google Scholar
  14. J. Yang, H. Guo, and Y. Miao, “Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging,” Nuclear Medicine and Biology, vol. 37, no. 8, pp. 873–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Xiong, Z. Cheng, X. Zhang et al., “Imaging chemically modified adenovirus for targeting tumors expressing integrin αvβ3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene,” Journal of Nuclear Medicine, vol. 47, no. 1, pp. 130–139, 2006. View at Scopus
  16. Z. Cheng, J. Chen, T. P. Quinn, and S. S. Jurisson, “Radioiodination of rhenium cyclized α-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma,” Cancer Research, vol. 64, no. 4, pp. 1411–1418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Bäckberg, N. Madjid, S. O. Ögren, and B. Meister, “Down-regulated expression of agouti-related protein (AGRP) mRNA in the hypothalamic arcuate nucleus of hyperphagic and obese tub/tub mice,” Molecular Brain Research, vol. 125, no. 1-2, pp. 129–139, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Shutter, M. Graham, A. C. Kinsey, S. Scully, R. Lüthy, and K. L. Stark, “Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice,” Genes and Development, vol. 11, no. 5, pp. 593–602, 1997. View at Scopus
  19. M. M. Ollmann, B. D. Wilson, Y. K. Yang et al., “Antagonism of Central Melanocortin receptors in vitro and in vivo by agouti-related protein,” Science, vol. 278, no. 5335, pp. 135–138, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. Jackson, J. C. McNulty, Y. K. Yang et al., “Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity,” Biochemistry, vol. 41, no. 24, pp. 7565–7572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Jackson, N. R. Douglas, B. Chai et al., “Structural and molecular evolutionary analysis of Agouti and Agouti-related proteins,” Chemistry and Biology, vol. 13, no. 12, pp. 1297–1305, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Kumar and S. L. Deutscher, “111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors,” Journal of Nuclear Medicine, vol. 49, no. 5, pp. 796–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. E. Mogensen and K. Solling, “Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 37, no. 6, pp. 477–486, 1977.
  24. S. Silbernagl, “The renal handling of amino acids and oligopeptides,” Physiological Reviews, vol. 68, no. 3, pp. 911–1007, 1988. View at Scopus
  25. J. Q. Chen, Z. Cheng, N. K. Owen et al., “Evaluation of an 111In-DOTA-rhenium cyclized α-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties,” Journal of Nuclear Medicine, vol. 42, no. 12, pp. 1847–1855, 2001. View at Scopus
  26. J. Q. Chen, Z. Cheng, T. J. Hoffman, S. S. Jurisson, and T. P. Quinn, “Melanoma-targeting properties of 99mtechnetium-labeled cyclic α-melanocyte-stimulating hormone peptide analogues,” Cancer Research, vol. 60, no. 20, pp. 5649–5658, 2000. View at Scopus
  27. L. Jiang, Z. Miao, R. H. Kimura et al., “Preliminary evaluation of 177Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 4, pp. 613–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Yoshimoto, K. Ogawa, K. Washiyama et al., “αvβ3 integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide,” International Journal of Cancer, vol. 123, no. 3, pp. 709–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Janssen, W. J. Oyen, I. Dijkgraaf et al., “Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model,” Cancer Research, vol. 62, no. 21, pp. 6146–6151, 2002. View at Scopus